Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis.
about
Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Comparison of chemotherapy plu ...... ensity score-matched analysis.
@en
Comparison of chemotherapy plu ...... ensity score-matched analysis.
@nl
type
label
Comparison of chemotherapy plu ...... ensity score-matched analysis.
@en
Comparison of chemotherapy plu ...... ensity score-matched analysis.
@nl
prefLabel
Comparison of chemotherapy plu ...... ensity score-matched analysis.
@en
Comparison of chemotherapy plu ...... ensity score-matched analysis.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of chemotherapy plu ...... ensity score-matched analysis.
@en
P2093
Bingwen Zou
Jianxin Xue
Meijuan Huang
Mengmeng Xiang
P2860
P304
P356
10.3892/OL.2018.8064
P50
P577
2018-02-15T00:00:00Z